Credo Tech’s Strong Quarter Can’t Lift Shares, Analysts Expect Rising AI Capex To Help

Credo Tech (CRDO) shares tanked despite upbeat Q3 earnings. Rosenblatt maintains Neutral with $125 PT. Needham reaffirms Buy with $220 PT.

Latest Ratings for CRDO

DateFirmActionFromTo Mar 2022Cowen & Co.MaintainsOutperform Mar 2022MizuhoMaintainsBuy Feb 2022Roth CapitalInitiates Coverage OnBuy

View More Analyst Ratings for CRDO

View the Latest Analyst Ratings

Importance Rank: 
1

read more